JF
BJDX icon

Jump Financial’s Bluejay Diagnostics BJDX Stock Holding History

Jump Financial’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-52
Closed -$1.32K – 1657
2024
Q3 		$1.32K Buy
+52
New +$3.72K ﹤0.01% 1585

Other funds holding BJDX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jump Financial's BJDX Position: Q4 2024 in Review

Jump Financial sold out of Bluejay Diagnostics (BJDX) in Q4 2024, closing a stake of 52 shares — an estimated $1.32K sold.

Jump Financial first reported a position in BJDX in Q3 2024 and held it in 1 quarter. The position peaked at $1.32K in Q3 2024. 3 funds tracked by Wall St. Rank hold BJDX as of Q4 2024.

  • Jump Financial reported no remaining Bluejay Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Jump Financial sold 52 Bluejay Diagnostics shares in Q4 2024, an estimated $1.32K.
  • Jump Financial first reported a position in Bluejay Diagnostics in Q3 2024 and held it in 1 quarter.
  • Jump Financial's Bluejay Diagnostics position peaked at $1.32K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.